Hale Advisors’ Post

🚨 Major industry insights happening NOW at our Michigan Roundtable! Brian Hanna, Cassin Coleman, Allison Ireton, and Rebecca Collett are sharing their experiences on the ground. These operator perspectives and regulatory insights are vital—wish you were here! 🗣️ #NCIA #MichiganSummit #CannabisIndustry #OperatorInsights #FOMO

Yesterday's live Florida Supreme Court reaction on our show was nothing short of epic! We were joined by Dan Ahrens COO of AdvisorShares, and had an insightful discussion about Florida's cannabis industry. Highlighted companies in our conversation included Trulieve, AYR Wellness Inc., Planet 13 Holdings, Inc., Cansortium Inc., Verano, Green Thumb Industries (GTI), and Cresco Labs. Don't miss the opportunity to catch up on the insightful analysis and viewpoints shared. Stay tuned for more updates and discussions on pivotal industry moments! (Watch the full discussion. The link is in the comments below.)

We're feeling honoured to have been invited to join #VetForumEurope again this year 😊 If you're going and would like to find out how behavioural science can help your business, why not schedule a chat with Dr Rebecca Maher MA VetMB PGCert MRCVS? Be quick though - due to other commitments she'll only be there for the first part of the meeting. So, DM us now if you'd like to grab a catch up 🙌 #InsideMinds #behaviouralscience #consumerpsychology #vetlife #animalhealth #veterinarian #veterinarysurgeon #veterinarynurse

Another 5-Star review for Sani-Bright!

With all the talk of GLP-1s, attention has been taken away from Humira as a cost-driver to employer benefit plans. The availability of multiple biosimilars means this shouldn't be the case as plans & providers should be steering patients towards the clinically comparable drugs. Also, interesting to see the decrease in total scripts but increase in average cost per script #benefits #drugs #humira

🌐 Embark on a Journey of Success with INJ Partners in the New Year! Elevate your business to unprecedented heights by joining our dynamic community of market research experts. Let's make 2024 your year of remarkable achievements! 🚀 #NewYearNewSuccess #INJPartners

We had the privilege of presenting to the Sanford Board of Directors and giving them a tour of Sterile Processing earlier this week. I was happy to share our preference card project with them. And yes, our preference cards on average have an 84% utilization rate and they've stayed that way for 4 years. It took a lot of dedication, collaboration, and trusting data to get to that point. If you're interested in learning more, check out this article: https://lnkd.in/gNDVpeib

                                                                                                                                    NEW ZEALAND COVID IN THE NEWS IN THE USA   TrialSite is a US based science platform whose mission is to drive awareness, introduce transparency, and facilitate engagement among people all over the world, from pharmaceutical professionals and academic researchers to regulators and healthcare professionals along with a wide array of the consuming public. They state "We value transparency, objectivity, and the scientific method in pursuit of the truth wherever it may lead us."   Evidently my concerns about the lack of transparency with respect to New Zealand’s Covid Royal enquiry are being reported Internationally but here in NZ not a murmur from the NZ bought media. Perhaps they are hoping for a financial bailout to save their increasingly obsolete media platforms or perhaps they have never really had the wellbeing of new Zealanders interests at heart but only their self-importance and the publication of clickbait media articles which provide revenue to their shareholders the detriment of all New Zealanders. Or perhaps they are afraid of being “cancelled” like veteran broadcaster Peter Williams who questioned the Labour Governments Covid elimination strategy. But surely there must be one journalist out there in NZ with a sliver of journalistic integrity that can put a spotlight on the lack of ethics and transparency of the NZ Covid enquiry. Or maybe Luxon could do a podcast on the importance of the Covid Royal Enquiry which is arguably of more critical importance than all the other items promoted in their 100 day plan because it may provide us with the tools to protect our people from largescale life threatening pathogenic infections that will inevitably confront our little piece of paradise in the foreseeable future. Jacinda Ardern was praised on the world stage for Eliminating Covid in NZ but it was short-lived and Covid is endemic in NZ. Now the International media commentary is around the slowness of the NZ Government to take action regarding the Covid enquiry and the excess mortality rates that countries around the world are experiencing following the rollout of Covid Vaccines. Jacinda Ardern's Achilles heel was her vanity that she could eliminate Covid in NZ when it was endemic in the rest of the world. Luxon's Achilles heel is that he wants to fix the economy as he sees this as a panacea for fixing all the woes of NZ. But pathogenic viruses dont give a pile of fecal matter about the economy. They just kill people. So Note to selfe Luxon "be prepared" you have a window of opportunity and an opportunity to investigate excess death mortality rates to prevent further deaths,   Sir Ray    

In Blue Mountain Holdings v. Bliss Nutraceuticals, the 11th Circuit upheld a U.S. District Court finding that Lighthouse Enterprises issued a naked license to Blue Mountain covering the trademark in question. Scott Hervey and Eric Caligiuri discuss this case and how to avoid bearing the risks of a naked license in this featured episode of The Briefing. Find the full episode here: https://bit.ly/462BWBV #nakedlicense #iplaw #trademarklaw #IntellectualProperty

Excited for my next webinar with the Citruslabs team! Clinical trials are a major investment for many brands, and it can be challenging to know where to start or even how to utilize the results. We’ll be exploring how to maximize the benefits of your clinical trials and effectively use research data to bolster your brand and marketing strategy. Sign up at the link below!